n Coronary stents Info and Facts 2017 | Pharma Insights

Coronary stents Info and Facts 2017



  • Stent in India is under category of medicine not in medical device section and it included in National List of Essential Medicines (NLEM). Recently Govt of India brought stents to price control authority National Pharmaceutical Pricing Authority (NPPA).
  • Two types stents used in angioplasty one is bare metal stent and drug eluting stent it is higher price than bare metal stent.
  •  India's stent industry valued  Rs1,400 crore, is heavily import-based.
  • Indian stent market share International companies enjoys 59.5% share such as Abbot vascular, Medtronic and Boston scientific and Indian companies accounted for 40.55%.
  • Stents are heavily overpriced 650percentage than original price.
  • In India where 30 million people suffer from cardiovascular problems and over two million die of heart attacks and strokes each year, stents have become essential. Every year, over 200,000 heart surgeries take place in the country.